2023 Health Insurance and Health Management Integrated Development Summit – Prospectus
Invitation to the 2023 Summit on the Integrated Development of Health Insurance and Health Management
With the continued advancement of the Healthy China strategy, coupled with sustained economic development and rising public health awareness in China, both the health insurance sector and the broader health industry have entered a phase of rapid growth.
In 2021, the “14th Five-Year Plan for National Healthcare Security” issued by the General Office of the State Council proposed encouraging commercial insurance institutions to provide comprehensive health insurance products and services across multiple fields, including medical care, disease management, rehabilitation, long-term care, and maternity. Previously, the General Office of the China Banking and Insurance Regulatory Commission (CBIRC) released the Notice on Regulating Health Management Services of Insurance Companies, further standardizing the health management service practices of insurance companies and promoting the steady development of commercial health insurance. The integration of health insurance with health management and the construction of a broader health ecosystem have become industry consensus and trends, emerging as a significant force supporting the healthy development of China’s healthcare sector.
As the official and authoritative media outlet under the National Financial Regulatory Administration, China Banking and Insurance Media plans to co-host the “2023 Conference on the Integrated Development of Health Insurance and Health Management” in partnership with the China Economic Media Association and the China Health Promotion Foundation. The conference will invite chairmen, general managers, senior executives, expert professors, and economists from national-level associations, financial regulatory bodies, renowned listed companies, large state-owned public mutual funds, commercial banks, major insurance institutions, well-known securities firms, and leading domestic and international universities’ finance departments, as well as relevant leaders from the National Financial Regulatory Administration. Additionally, the conference will collaborate with PwC, a globally renowned consulting firm, to release the report titled “Strategize and Act Swiftly: Seizing Blue Ocean Market Opportunities and Accelerating the Creation of a Localized ‘Health Insurance + Health Management’ New Ecosystem.”
We cordially invite the principal executives and heads of relevant departments from your company to attend the meeting.
China Economic Media Association, September 12, 2023
Proposed Agenda
Organizer:
China Banking and Insurance Media Co., Ltd.
China Economic Media Association
China Health Promotion Foundation
Supporting Organizations:Shenzhen Longhua District Bureau of Industry and Information Technology
Co-organizers:
PICC Health Insurance Company Limited
Chinese National Health Association, Committee of Oncology Prevention and Treatment
Huarui Tongkang Biotechnology (Shenzhen) Co., Ltd.
Organizer:Shenzhen Allensven Institute of Precision Medicine
Meeting Time:September 21, 2023
Venue:3rd Floor, Longhua Grand Ballroom, DoubleTree by Hilton Hotel Shenzhen Longhua
9:00–9:40 Opening Remarks
Wang Wei, Secretary of the Longhua District Committee of the Shenzhen Municipal Party Committee
Leaders of the Shenzhen Municipal Health Commission and Related Departments
Zhang Lixing, Director of the Shenzhen Regulatory Bureau of the National Financial Regulatory Administration
Lu Jiyun, Deputy Secretary-General of the China Health Promotion Foundation and Former Vice President of the PLA General Hospital
Zhu Jinyuan, Party Secretary and Chairman of China Banking and Insurance Media
Party Secretary and President of China Rural Finance Magazine
9:40–10:40 Keynote Address
Theme: Putting People First to Drive High-Quality Development of Health Insurance
Zhou Yanli, Member of the 13th National Committee of the Chinese People's Political Consultative Conference, Former Vice Chairman of the China Insurance Regulatory Commission
Theme: Innovation in Health Governance Centered on Public Experience
Chen Hu, Deputy Director of the Medical Management Center, National Health Commission
Topic: Strengthening Cancer Prevention and Control to Promote Public Health
Chen Wanqing, Director of the Office for Early Prevention and Treatment of Cancer, National Cancer Center
Chairman of the Oncology Prevention and Control Professional Committee, Chinese National Health Association
10:40-11:40 Institutional Sharing
Topic: Pain Points in Insurance Consumption and Directions for Innovation in Health Insurance Products
Shao Liduo, Party Secretary and President of PICC Health
Topic: Reflections and Practices on Reshaping the Value Chain of the Health Insurance Business
Shang Jiaoyan, General Manager of Pacific Health Insurance
Title: How Third-Party Health Management Facilitates Innovation in the Insurance Business
Zhou Ji, Chairman of Huarui Tongkang
11:40-12:00 Report Release
“Reshaping the Ecosystem: Exploring the Integrated Development of Health Insurance and Health Management”
Li Yanshu, Partner, Healthcare Consulting, PwC China
14:00–15:30 Thematic Seminar (I): Pathways for Collaborative Development Among Healthcare Providers, Pharmaceutical Companies, and Insurance Payers
The report to the 20th National Congress of the Communist Party of China called for “advancing the Healthy China initiative” and “promoting the coordinated development and governance of medical insurance, healthcare services, and pharmaceuticals,” thereby charting the course for deepening healthcare system reforms. It has become a broad industry consensus to integrate diverse entities across healthcare, pharmaceuticals, and insurance, leverage the payer position of insurers, and jointly promote the integrated development of health management and health insurance. How can healthcare, pharmaceuticals, and insurance achieve deeper integration? What new business models will emerge from this convergence? This topic aims to explore specific pathways and practical experiences in fostering the coordinated development of healthcare, pharmaceuticals, and insurance.
Keynote Speech:
Yu Ning, Assistant General Manager of Ping An Health Insurance Company of China, Ltd.
Zhang Jing, Head of Medical Insurance Actuarial Pricing Team, Swiss Re China
Roundtable Discussion:
Moderator:
Cai Yongjiang, Member of the Tumor Prevention and Treatment Professional Committee of the China National Health Association
Director, Health Management Center, Peking University Shenzhen Hospital
Proposed Invited Institutions:
Kou Chao, President of Pan-China Insurance Sales Service Group
Ma Xiaowu, Executive Vice President of Qingsong Group
Zeng Zhuo, Chief Marketing Officer of Sino-UK Life Insurance
Lin Junfeng, Head of Strategic Enterprise Clients and Insurance Business, JD Health
Dong Wutao, Executive Director and General Manager of Medx Insurance Brokers
15:30-17:00 Thematic Seminar (II): New Trends in Investment in the Big Health Industry
As public attention to and demand for health continue to rise, the broader health industry has become a global hotspot and a new engine for economic growth. Research institutions project that China’s broader health industry will generate RMB 9.0 trillion in revenue by 2024. How can health insurers seize the opportunities presented by the integration of the broader health industry and accelerate innovative development? What new trends will shape the next wave of investment in this sector? This theme aims to discuss the trends shaping the construction of the health industry and the areas attracting capital interest.
Roundtable Discussion:
Moderator:
Dai Yunfei, Executive Director, Taiping Financial Holdings Equity Investment Fund
Institutions Proposed for Invitation:
Li YingShenzhen LonghuaChairman of Industrial Capital Investment Co., Ltd.
Liu HangTaipingDeputy General Manager, Planning and Research Department, Industrial Investment Management Co., Ltd.
Xu WeiChinaDeputy General Manager, Xinhongsheng Private Equity Fund Management Co., Ltd.
Jiang LiChina Life Insurance (Stock)RightsManaging Director, Investment Co., Ltd.
Huang Jiang, Vice President of Defu Capital